Revision To Hepatitis Relief: 5-Year Extension To Benefit Claims
This article was originally published in PharmAsia News
Executive Summary
In Japan’s House of Councilors’ plenary session held Sept. 7, members unanimously agreed that the payment claim period for hepatitis C patients infected through medication should be extended by five years, and amendments were made to the Relief Act.